- ￥6500
- 齐源
- 331825
- 国产/进口
- 2025年07月16日
- PG
- 小鼠
- 人
6 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
齐源
- 库存：
999
- 靶点：
CD319
- 级别：
CD319 (CRACC) Antibody
- 目录编号：
CD319 (CRACC) Antibody
- 克隆性：
单克隆
- 抗原来源：
小鼠
- 保质期：
CD319 (CRACC) Antibody
- 抗体英文名：
TotalSeq™-B0830 anti-human CD319 (CRACC) Antibody
- 抗体名：
CD319 (CRACC) Antibody
- 标记物：
CD319 (CRACC) Antibody
- 宿主：
小鼠
- 适应物种：
人
- 免疫原：
CD319 (CRACC) Antibody
- 亚型：
CD319 (CRACC) Antibody
- 形态：
CD319 (CRACC) Antibody
- 应用范围：
PG
- 保存条件：
2-8℃
- 浓度：
0.5 mg/mL
- 规格：
10 µg
TotalSeq™-B0830 anti-human CD319 (CRACC) Antibody详细如下：
Description ：CD319 is a single-pass type l transmembrane glycoprotein, expressed on NK cells, subsets ofmature dendritic cells, activated B cells, and cytotoxic lymphocytes, but not in promyelocytic, Bor T cell lines. Expression is highest in the spleen, lymph nodes, and peripheral bloodleukocytes, and lowest in bone marrow. Additionally, it is expressed in the small intestine,stomach, appendix, lung, and trachea. CD319 is tyrosine phosphorylated in activated NK cellsand is associated with 19 and 39 kD proteins. CD319 has homology with the CD2 family ofreceptors within the Ig superfamily. Some of the CD2 members stimulate cytotoxicity throughthe CD319 associated protein.
Verified Reactivity ：Human
Reported Reactivity ：Cynomolgus
Antibody Type ：Monoclonal
Host Species ：Mouse
Immunogen ：CRACC-Human IgG1 fusion protein
Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 1 mM EDTA
Preparation ：The antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer underoptimal conditions.
Concentration ：0.5 mg/mL
Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application ：PG - Quality tested
Recommended Usage ：Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-B antibodies arecompatible with 10x Genomics Single Cell Gene Expression Solutions.
To maximize performance, it is strongly recommended that the reagent be titrated for eachapplication, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2- 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to thecell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent fortitration is ≤ 1.0 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™protocol for specific staining instructions.
Description ：CD319 is a single-pass type l transmembrane glycoprotein, expressed on NK cells, subsets ofmature dendritic cells, activated B cells, and cytotoxic lymphocytes, but not in promyelocytic, Bor T cell lines. Expression is highest in the spleen, lymph nodes, and peripheral bloodleukocytes, and lowest in bone marrow. Additionally, it is expressed in the small intestine,stomach, appendix, lung, and trachea. CD319 is tyrosine phosphorylated in activated NK cellsand is associated with 19 and 39 kD proteins. CD319 has homology with the CD2 family ofreceptors within the Ig superfamily. Some of the CD2 members stimulate cytotoxicity throughthe CD319 associated protein.
Verified Reactivity ：Human
Reported Reactivity ：Cynomolgus
Antibody Type ：Monoclonal
Host Species ：Mouse
Immunogen ：CRACC-Human IgG1 fusion protein
Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 1 mM EDTA
Preparation ：The antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer underoptimal conditions.
Concentration ：0.5 mg/mL
Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application ：PG - Quality tested
Recommended Usage ：Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-B antibodies arecompatible with 10x Genomics Single Cell Gene Expression Solutions.
To maximize performance, it is strongly recommended that the reagent be titrated for eachapplication, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2- 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to thecell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent fortitration is ≤ 1.0 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™protocol for specific staining instructions.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation)：
1. Bouchon A, et al. 2001. J. Immunol. 167:551721.
2. Tassi I and Colonna M. 2005. J. Immunol. 175:79968002.
3. Veillette A. 2006. Immunol. Rev. 214:2234.
1. Bouchon A, et al. 2001. J. Immunol. 167:551721.
2. Tassi I and Colonna M. 2005. J. Immunol. 175:79968002.
3. Veillette A. 2006. Immunol. Rev. 214:2234.
文献支持
TotalSeq™-B0830 抗人 CD319 (CRACC) 抗体
￥6500
